Safety and Efficacy of Imeglimin for Type 2 Diabetes Mellitus in Patients With Heart Failure
Authors
- Yusuke Akazawa (ORCID: https://orcid.org/0000-0002-5127-3565)
- Akinori Higaki (ORCID: https://orcid.org/0000-0002-0827-874X)
- Osamu Yamaguchi (ORCID: https://orcid.org/0000-0002-7461-369X)
- Tomoaki Nishikawa
- Shunsuke Tamaki (ORCID: https://orcid.org/0000-0001-5642-3836)
- Toru Miyoshi (ORCID: https://orcid.org/0000-0002-9039-3439)
- Ryusuke Horie (ORCID: https://orcid.org/0000-0003-1959-899X)
- Tomoki Fujisawa (ORCID: https://orcid.org/0000-0003-3859-7087)
- KEISHO KUROKAWA
- KIMIHIRO YOSHIMOTO
- Yoko M. Nakao (ORCID: https://orcid.org/0000-0002-3627-5626)
- Hiroshi Kawakami (ORCID: https://orcid.org/0000-0001-7839-0246)
- Shunichi Miyazaki (ORCID: https://orcid.org/0000-0002-0586-5447)
- Kazuhide Inoue (ORCID: https://orcid.org/0000-0003-0385-9577)
- Koji Nishimura (ORCID: https://orcid.org/0000-0003-0507-8184)
- S Ikeda
- Haruhiko Higashi
Publication Details
- Journal
- In Vivo
- Published
- 2024-12-31
- DOI
- https://doi.org/10.21873/invivo.13838
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.36